4.4 Article

Proteasome impairment in neural cells derived from HMSN-P patient iPSCs

Journal

MOLECULAR BRAIN
Volume 10, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s13041-017-0286-y

Keywords

HMSN-P; TFG; UPS; Neurodegeneration; iPSCs; Gene correction; CRISPR-Cas9

Categories

Funding

  1. Japan Agency for Medical Research and Development (AMED)
  2. Research Project for Practical Applications of Regenerative Medicine from AMED
  3. AMED
  4. Mochida Memorial Foundation for Medical and Pharmaceutical Research
  5. Daiichi Sankyo Foundation of Life Science
  6. Ministry of Health, Labor and Welfare of Japan
  7. Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis from AMED

Ask authors/readers for more resources

Hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P) is caused by a heterozygous mutation (P285L) in Tropomyosin-receptor kinase Fused Gene (TFG), histopathologically characterized by progressive spinal motor neuron loss with TFG cytosolic aggregates. Although the TFG protein, found as a type of fusion oncoprotein, is known to facilitate vesicle transport from endoplasmic reticulum (ER) to Golgi apparatus at ER exit site, it is unclear how mutant TFG causes motor neuron degeneration. Here we generated induced pluripotent stem cells (iPSCs) from HMSN-P patients, and differentiated the iPSCs into neural cells with spinal motor neurons (iPS-MNs). We found that HMSN-P patient iPS-MNs exhibited ubiquitin proteasome system (UPS) impairment, and HMSN-P patient iPS-MNs were vulnerable to UPS inhibitory stress. Gene correction of the mutation in TFG using the CRISPR-Cas9 system reverted the cellular phenotypes of HMSN-P patient iPS-MNs. Collectively, these results suggest that our cellular model with defects in cellular integrity including UPS impairments may lead to identification of pathomechanisms and a therapeutic target for HMSN-P.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available